Ovarian hyperstimulation syndrome (OHSS) is a complication of fertility treatments involving the stimulation of the ovaries. It is caused by the release of excessive amounts of hormones during fertility treatments, such as human chorionic gonadotropin (hCG), follicle stimulating hormone (FSH) or luteinizing hormone (LH). OHSS can affect both women undergoing fertility treatments and those who have not had any fertility treatments. Signs and symptoms of OHSS may include abdominal pain, bloating, nausea, vomiting, diarrhea, rapid weight gain, shortness of breath, and feeling lightheaded or dizzy. In severe cases, OHSS can cause fluid to accumulate in the abdomen and chest, resulting in a swollen abdomen, difficulty breathing, and decreased urine output. OHSS is usually self-limiting and resolves within a few days or weeks, however, in severe cases, it can be life-threatening and require hospitalization. Treatment of OHSS depends on the severity of the symptoms, but typically includes bed rest, intravenous fluids, and medications to help reduce the symptoms.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia